報價延遲最少15分鐘:2025/01/21 08:57 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
-- 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.67/-0.58
|
|
企業價值
29.37M
|
| 資產負債 |
|
每股賬面淨值
0.16
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
51.87M
|
|
每股收益
3.39
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/21 08:57 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim. |